Toronto Dominion Bank Exagen Inc. Transaction History
Toronto Dominion Bank
- $49.5 Billion
- Q1 2025
A detailed history of Toronto Dominion Bank transactions in Exagen Inc. stock. As of the latest transaction made, Toronto Dominion Bank holds 891,366 shares of XGN stock, worth $5.88 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
891,366
Previous 891,366
-0.0%
Holding current value
$5.88 Million
Previous $3.65 Million
12.42%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding XGN
# of Institutions
40Shares Held
6.17MCall Options Held
3.4KPut Options Held
18.4K-
Rtw Investments, LP New York, NY1.51MShares$9.98 Million0.09% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY532KShares$3.51 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$3.24 Million0.0% of portfolio
-
Morgan Stanley New York, NY486KShares$3.21 Million0.0% of portfolio
-
Perkins Capital Management Inc423KShares$2.79 Million1.69% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $107M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...